✦ LIBER ✦

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer

✍ Scribed by Robert W. Hathorn; Cho-Lea Tso; Randhir Kaboo; Shen Pang; Robert Figlin; Charles Sawyers; Jean B. Dekernion; Arie Belldegrun

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 899 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941001)74:7<1904::aid-cncr2820740713>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxic In vitro function in patients

Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2

✍ Cristina Feruglio; Renato Zambello; Livio Trentin; Pietro Bulian; Tiziano France 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Modulation of human lymphoblastoid inter

Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study

✍ Bruno Neri; Carlo Fiorelli; Fausto Moroni; Giulio Nicita; Maria Cristina Paolett 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 3 views

Intratumoral administration of a 1,2-dim

Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma

✍ Evanthia Galanis; Patrick A. Burch; Ronald L. Richardson; Bradley Lewis; Henry C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Subcutaneous interleukin-2 and interfero

Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin-2 and interferon α : Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie

✍ Alain Ravaud; Rémy Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The main objective of this trial was to evaluate the combination of subcutaneous (sc) interleukin-2 (il-2) with interferon alpha-2a (ifn-alpha) in the treatment of patients with metastatic renal cell carcinoma (mrcc) compared with a previous trial that used continuous-infusion il-2 a

Interleukin-2, interferon-α, 5-fluoroura

Interleukin-2, interferon-α, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma : A prospective Phase II study: The experience of Rambam and Lin Medical Centers 1996-2000

✍ Eliahu Gez; Raphael Rubinov; Diana Gaitini; Shimon Meretyk; Lael-Anson Best; Ofe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND The current study evaluated the efficacy and toxicity of interleukin‐2 (IL‐2), interferon‐α (IFN‐α), 5‐fluorouracil (5‐FU), and vinblastine (VBL) in the treatment of metastatic renal cell carcinoma (MRCC). ## METHODS Sixty‐two MRCC patients, median age 63 years, receive

Acquired immunity in nude mice induced b

Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by In vivo gene transfer using retrovirus

✍ Masaki Kimura; Yu Yoshida; Mitsuro Narita; Keizo Takenaga; Toshinao Takenouchi; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 330 KB 👁 2 views

We have examined the anti-tumor effect in nude mice caused by human pancreatic cancer cells (AsPC-1) modified to secrete IL-2 or IL-4. Loss of tumorigenicity of cytokineproducing, but not wild-type, cells was observed despite their unaltered in vitro proliferation rates; and these anti-tumor effects